Are you Dr. Ayash?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 53 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4100 John R St
Karmanos Cancer Inst
Detroit, MI 48201Phone+1 800-527-6266Fax+1 313-576-8767- Is this information wrong?
Summary
- Dr. Lois Ayash, MD is an oncologist in Detroit, Michigan. She is currently licensed to practice medicine in Michigan and Massachusetts. She is affiliated with Karmanos Cancer Center, DMC Harper University Hospital, and DMC Detroit Receiving Hospital & University Health Center.
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1988 - 1990
SUNY Upstate Medical UniversityFellowship, Hematology and Medical Oncology, 1985 - 1988
St Vincent HospitalResidency, Internal Medicine, 1981 - 1984
University of Massachusetts Medical SchoolClass of 1981
Certifications & Licensure
MI State Medical License 1997 - 2026
MA State Medical License 1983 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease Start of enrollment: 2007 Jan 01
- Dasatinib for Modulating Immune System After Autologous Stem Cell Transplants for Multiple Myeloma, Non-Hodgkin, or Hodgkin Lymphoma Start of enrollment: 2015 Feb 12
- Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic Malignancies Start of enrollment: 2012 May 01
Publications & Presentations
PubMed
- Allogeneic stem cell transplant outcomes between TBI-containing reduced intensity and myeloablative conditioning regimens for ALL in complete remission.Dipenkumar Modi, Samer Alkassis, Seongho Kim, Andrew Kin, Abhinav Deol, Lois Ayash, Voravit Ratanatharathorn, Joseph P Uberti> ;Leukemia & Lymphoma. 2023 May 8
- Role of High-Dose Adjuvant Chemotherapy Followed by Autologous Stem Cell Transplantation in Locally Advanced Triple-Negative Breast Cancer: A Retrospective Chart Review.Bayan Al-Share, Hadeel Assad, Judith Abrams, Abhinav Deol, Asif Alavi, Dipenkumar Modi, Andrew Kin, Voravit Ratanatharathorn, Joseph Uberti, Lois Ayash> ;Journal of Oncology. 2022 Jan 1
- 5 citationsImproved post-ASCT survival of relapsed/refractory classical Hodgkin lymphoma patients in the era of novel agents.Harsh Shah, Hyejeong Jang, Paramveer Singh, Jorgena Kosti, Andrew Kin, Asif Alavi, Voravit Ratanatharathorn, Lois Ayash, Joseph P. Uberti, Radhakrishnan Ramchandren, S...> ;Leukemia & Lymphoma. 2021 Nov 15
- Join now to see all
Press Mentions
Graduating Fellow and Karmanos Breast Cancer Specialist Co-Author Manuscript on Triple Negative Breast Cancer with BMT FacultyOctober 18th, 2022
Grant Support
- Tetrathiomolybdate As Maintenance Therapy After Autologous Peripheral Stem CellNational Center For Research Resources2004–2005
Professional Memberships
- Member
Hospital Affiliations
DMC Detroit Receiving Hospital & University Health CenterDetroit, Michigan
DMC Harper University HospitalDetroit, Michigan
Karmanos Cancer CenterDetroit, Michigan
